

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.77748561 |
| 2 | cellular response to type I interferon (GO:0071357) | 4.28255320 |
| 3 | type I interferon signaling pathway (GO:0060337) | 4.28255320 |
| 4 | response to type I interferon (GO:0034340) | 4.22293037 |
| 5 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.08016562 |
| 6 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.02404046 |
| 7 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.79255569 |
| 8 | cellular response to virus (GO:0098586) | 3.69384071 |
| 9 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.55543197 |
| 10 | positive regulation of type 2 immune response (GO:0002830) | 3.54915187 |
| 11 | lipoxygenase pathway (GO:0019372) | 3.54333642 |
| 12 | germinal center formation (GO:0002467) | 3.32185246 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 3.31571819 |
| 14 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.27862719 |
| 15 | regulation of RIG-I signaling pathway (GO:0039535) | 3.26851122 |
| 16 | regulation of type 2 immune response (GO:0002828) | 3.17478301 |
| 17 | regulation of platelet aggregation (GO:0090330) | 3.15511488 |
| 18 | adenosine receptor signaling pathway (GO:0001973) | 3.12096105 |
| 19 | response to peptidoglycan (GO:0032494) | 3.08798228 |
| 20 | regulation of chronic inflammatory response (GO:0002676) | 3.08062825 |
| 21 | cellular response to interferon-alpha (GO:0035457) | 3.06116397 |
| 22 | regulation of platelet activation (GO:0010543) | 2.99046675 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.96185923 |
| 24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93642118 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 2.92938098 |
| 26 | granulocyte activation (GO:0036230) | 2.92936430 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 2.92662087 |
| 28 | negative regulation of viral genome replication (GO:0045071) | 2.88224999 |
| 29 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.88061328 |
| 30 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.83118467 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.83106162 |
| 32 | modulation by symbiont of host cellular process (GO:0044068) | 2.80959624 |
| 33 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.78769583 |
| 34 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78104078 |
| 35 | peptide catabolic process (GO:0043171) | 2.76840873 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 2.76651673 |
| 37 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.75491501 |
| 38 | plasma membrane fusion (GO:0045026) | 2.73730627 |
| 39 | negative regulation of platelet activation (GO:0010544) | 2.70895421 |
| 40 | NIK/NF-kappaB signaling (GO:0038061) | 2.67518384 |
| 41 | activation of MAPKKK activity (GO:0000185) | 2.66413569 |
| 42 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.65870975 |
| 43 | neutrophil activation (GO:0042119) | 2.65755720 |
| 44 | hemoglobin metabolic process (GO:0020027) | 2.65246867 |
| 45 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.64196650 |
| 46 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.62831768 |
| 47 | regulation of vitamin metabolic process (GO:0030656) | 2.62661637 |
| 48 | cellular response to exogenous dsRNA (GO:0071360) | 2.61325087 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 2.58473978 |
| 50 | negative regulation of interleukin-12 production (GO:0032695) | 2.58424593 |
| 51 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.56858755 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.56784312 |
| 53 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.56784312 |
| 54 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.56784312 |
| 55 | modulation by symbiont of host immune response (GO:0052553) | 2.56784312 |
| 56 | positive regulation by symbiont of host defense response (GO:0052509) | 2.56784312 |
| 57 | modulation by symbiont of host defense response (GO:0052031) | 2.56784312 |
| 58 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.56558288 |
| 59 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.55732780 |
| 60 | decidualization (GO:0046697) | 2.54074013 |
| 61 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.53167768 |
| 62 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.52192232 |
| 63 | regulation of integrin activation (GO:0033623) | 2.50504755 |
| 64 | regulation of chemokine biosynthetic process (GO:0045073) | 2.49729686 |
| 65 | oxygen transport (GO:0015671) | 2.48618870 |
| 66 | detection of bacterium (GO:0016045) | 2.48496409 |
| 67 | myeloid dendritic cell differentiation (GO:0043011) | 2.47898994 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.47234966 |
| 69 | negative regulation of viral entry into host cell (GO:0046597) | 2.47031442 |
| 70 | response to interferon-alpha (GO:0035455) | 2.46363870 |
| 71 | detection of other organism (GO:0098543) | 2.44489705 |
| 72 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.44376645 |
| 73 | fibril organization (GO:0097435) | 2.42000113 |
| 74 | positive regulation of receptor recycling (GO:0001921) | 2.41051944 |
| 75 | hyaluronan catabolic process (GO:0030214) | 2.39513842 |
| 76 | regulation of early endosome to late endosome transport (GO:2000641) | 2.39483741 |
| 77 | regulation of podosome assembly (GO:0071801) | 2.37352461 |
| 78 | modulation by virus of host process (GO:0019054) | 2.36081306 |
| 79 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.36031333 |
| 80 | regulation of T-helper cell differentiation (GO:0045622) | 2.35975462 |
| 81 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.34918497 |
| 82 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.34692796 |
| 83 | gas transport (GO:0015669) | 2.34383394 |
| 84 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.30548784 |
| 85 | regulation of immunoglobulin secretion (GO:0051023) | 2.29945405 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 2.29686562 |
| 87 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.29462920 |
| 88 | negative regulation of type 2 immune response (GO:0002829) | 2.28196324 |
| 89 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.27793011 |
| 90 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.27772122 |
| 91 | leukocyte degranulation (GO:0043299) | 2.27297267 |
| 92 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.26450497 |
| 93 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.24634418 |
| 94 | glycosphingolipid catabolic process (GO:0046479) | 2.22866576 |
| 95 | positive regulation of interleukin-6 production (GO:0032755) | 2.22028858 |
| 96 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.21509661 |
| 97 | cellular response to arsenic-containing substance (GO:0071243) | 2.20781611 |
| 98 | virion attachment to host cell (GO:0019062) | 2.20336210 |
| 99 | adhesion of symbiont to host cell (GO:0044650) | 2.20336210 |
| 100 | negative regulation of viral process (GO:0048525) | 2.20107472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.53893186 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.86483626 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.81525081 |
| 4 | GATA1_19941826_ChIP-Seq_K562_Human | 2.73392606 |
| 5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.49673226 |
| 6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.47492483 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.39845774 |
| 8 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.23951622 |
| 9 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.20080847 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19560623 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16290127 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.14926749 |
| 13 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.09605703 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06495764 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98970538 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97677777 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.96575368 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.96263190 |
| 19 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.94353023 |
| 20 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.88936861 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88141811 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.85926420 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.84402941 |
| 24 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.83835037 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83306373 |
| 26 | GATA2_19941826_ChIP-Seq_K562_Human | 1.77955049 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.77602888 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.75572373 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73580275 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72688647 |
| 31 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.68761953 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64765328 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.63131312 |
| 34 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.61956058 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61101442 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.61099132 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.60976488 |
| 38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59703109 |
| 39 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57833328 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.56661988 |
| 41 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.56059297 |
| 42 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.55906098 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52755984 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52565305 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52186381 |
| 46 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.51748693 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50464121 |
| 48 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50020298 |
| 49 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.49240643 |
| 50 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.48364620 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48132886 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.46636487 |
| 53 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46619367 |
| 54 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43526364 |
| 55 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42773535 |
| 56 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42699539 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.39858507 |
| 58 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39679265 |
| 59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.37987331 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34139446 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33982929 |
| 62 | P68_20966046_ChIP-Seq_HELA_Human | 1.33245382 |
| 63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.32650233 |
| 64 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.29999760 |
| 65 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28071440 |
| 66 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26888860 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.23362501 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.22757887 |
| 69 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20861000 |
| 70 | MAF_26560356_Chip-Seq_TH2_Human | 1.20186701 |
| 71 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.20127255 |
| 72 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17200915 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17168781 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16944458 |
| 75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14737021 |
| 76 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13985921 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12867417 |
| 78 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11203867 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10895926 |
| 80 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10489911 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09170667 |
| 82 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09054533 |
| 83 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.08018897 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07767171 |
| 85 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07505267 |
| 86 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.06506645 |
| 87 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06262796 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05707801 |
| 89 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.05589844 |
| 90 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04797739 |
| 91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04370519 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03991613 |
| 93 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02992325 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01665341 |
| 95 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01017708 |
| 96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00972445 |
| 97 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00717899 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00683570 |
| 99 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99459550 |
| 100 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99163822 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.50658114 |
| 2 | MP0005464_abnormal_platelet_physiology | 3.61651060 |
| 3 | MP0003724_increased_susceptibility_to | 3.38329390 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.01835951 |
| 5 | MP0003436_decreased_susceptibility_to | 2.69277580 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.61565630 |
| 7 | MP0004510_myositis | 2.61336585 |
| 8 | MP0008004_abnormal_stomach_pH | 2.54146690 |
| 9 | MP0005410_abnormal_fertilization | 2.53064597 |
| 10 | MP0005451_abnormal_body_composition | 2.43145839 |
| 11 | MP0009785_altered_susceptibility_to | 2.39256920 |
| 12 | MP0006082_CNS_inflammation | 2.39172992 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.36423607 |
| 14 | MP0004947_skin_inflammation | 2.28378619 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.16496549 |
| 16 | MP0003656_abnormal_erythrocyte_physiolo | 2.14896963 |
| 17 | MP0003453_abnormal_keratinocyte_physiol | 2.06419098 |
| 18 | MP0005000_abnormal_immune_tolerance | 1.97934139 |
| 19 | MP0005025_abnormal_response_to | 1.96483465 |
| 20 | MP0005083_abnormal_biliary_tract | 1.95067206 |
| 21 | MP0001545_abnormal_hematopoietic_system | 1.90301190 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 1.90301190 |
| 23 | MP0009840_abnormal_foam_cell | 1.87616199 |
| 24 | MP0000343_altered_response_to | 1.85014246 |
| 25 | MP0005387_immune_system_phenotype | 1.84676892 |
| 26 | MP0001790_abnormal_immune_system | 1.84676892 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.79084689 |
| 28 | MP0005310_abnormal_salivary_gland | 1.73813495 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.72382819 |
| 30 | MP0003566_abnormal_cell_adhesion | 1.69788159 |
| 31 | MP0002419_abnormal_innate_immunity | 1.69642527 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.63033445 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.62853793 |
| 34 | MP0002132_abnormal_respiratory_system | 1.62682343 |
| 35 | MP0009764_decreased_sensitivity_to | 1.57880504 |
| 36 | MP0003828_pulmonary_edema | 1.55611303 |
| 37 | MP0002723_abnormal_immune_serum | 1.54062795 |
| 38 | MP0005671_abnormal_response_to | 1.47750831 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.47387189 |
| 40 | MP0003879_abnormal_hair_cell | 1.46329977 |
| 41 | MP0000858_altered_metastatic_potential | 1.45990240 |
| 42 | MP0009278_abnormal_bone_marrow | 1.45764876 |
| 43 | MP0000685_abnormal_immune_system | 1.42315606 |
| 44 | MP0001800_abnormal_humoral_immune | 1.41857551 |
| 45 | MP0001853_heart_inflammation | 1.40608938 |
| 46 | MP0002332_abnormal_exercise_endurance | 1.37769096 |
| 47 | MP0003075_altered_response_to | 1.37402277 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.36747587 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 1.36276969 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.29557014 |
| 51 | MP0003091_abnormal_cell_migration | 1.29527582 |
| 52 | MP0002796_impaired_skin_barrier | 1.29455051 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.25107746 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.22872245 |
| 55 | MP0001819_abnormal_immune_cell | 1.18312360 |
| 56 | MP0008469_abnormal_protein_level | 1.17389772 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.17035251 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.13688948 |
| 59 | MP0002405_respiratory_system_inflammati | 1.12156365 |
| 60 | MP0005377_hearing/vestibular/ear_phenot | 1.12089827 |
| 61 | MP0003878_abnormal_ear_physiology | 1.12089827 |
| 62 | MP0005023_abnormal_wound_healing | 1.09691690 |
| 63 | MP0005501_abnormal_skin_physiology | 1.09441922 |
| 64 | MP0008874_decreased_physiological_sensi | 1.08239975 |
| 65 | MP0005164_abnormal_response_to | 1.06930007 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.05255352 |
| 67 | MP0009763_increased_sensitivity_to | 1.03550562 |
| 68 | MP0003448_altered_tumor_morphology | 1.02519143 |
| 69 | MP0002398_abnormal_bone_marrow | 1.00905749 |
| 70 | MP0008260_abnormal_autophagy | 0.98190617 |
| 71 | MP0002254_reproductive_system_inflammat | 0.97571626 |
| 72 | MP0005165_increased_susceptibility_to | 0.97353751 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 0.95498396 |
| 74 | MP0001542_abnormal_bone_strength | 0.95055627 |
| 75 | MP0001851_eye_inflammation | 0.90100191 |
| 76 | MP0000249_abnormal_blood_vessel | 0.89711199 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 0.89599207 |
| 78 | MP0005275_abnormal_skin_tensile | 0.88860754 |
| 79 | MP0000716_abnormal_immune_system | 0.88208928 |
| 80 | MP0000465_gastrointestinal_hemorrhage | 0.88166610 |
| 81 | MP0002429_abnormal_blood_cell | 0.87520236 |
| 82 | MP0004883_abnormal_blood_vessel | 0.85919442 |
| 83 | MP0005166_decreased_susceptibility_to | 0.85660174 |
| 84 | MP0001849_ear_inflammation | 0.84635372 |
| 85 | MP0001663_abnormal_digestive_system | 0.82034201 |
| 86 | MP0005390_skeleton_phenotype | 0.81997100 |
| 87 | MP0000678_abnormal_parathyroid_gland | 0.81151328 |
| 88 | MP0001216_abnormal_epidermal_layer | 0.80674493 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.80459754 |
| 90 | MP0002722_abnormal_immune_system | 0.80382307 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.77936081 |
| 92 | MP0003045_fibrosis | 0.77624184 |
| 93 | MP0000689_abnormal_spleen_morphology | 0.74071079 |
| 94 | MP0010234_abnormal_vibrissa_follicle | 0.72435350 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.71032605 |
| 96 | MP0006054_spinal_hemorrhage | 0.70345353 |
| 97 | MP0005535_abnormal_body_temperature | 0.69890534 |
| 98 | MP0009931_abnormal_skin_appearance | 0.69425585 |
| 99 | MP0005365_abnormal_bile_salt | 0.66000992 |
| 100 | MP0003763_abnormal_thymus_physiology | 0.65885653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 4.82878863 |
| 2 | Purpura (HP:0000979) | 4.73909467 |
| 3 | Petechiae (HP:0000967) | 4.56955338 |
| 4 | Menorrhagia (HP:0000132) | 4.11604492 |
| 5 | Nasal polyposis (HP:0100582) | 3.97631638 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.69639407 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 3.63075027 |
| 8 | Increased mean platelet volume (HP:0011877) | 3.59968417 |
| 9 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.59923774 |
| 10 | Epistaxis (HP:0000421) | 3.59838115 |
| 11 | Abnormal platelet volume (HP:0011876) | 3.58035063 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 3.41878444 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.41384534 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.41384534 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.41384534 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.20290974 |
| 17 | Male infertility (HP:0003251) | 3.18443013 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.11890463 |
| 19 | Poikilocytosis (HP:0004447) | 3.04037505 |
| 20 | Gingival bleeding (HP:0000225) | 2.96349125 |
| 21 | Eczematoid dermatitis (HP:0000976) | 2.93068236 |
| 22 | Testicular neoplasm (HP:0010788) | 2.81774244 |
| 23 | Polycythemia (HP:0001901) | 2.77530240 |
| 24 | Orchitis (HP:0100796) | 2.70387123 |
| 25 | Increased IgE level (HP:0003212) | 2.70057784 |
| 26 | Abnormal platelet function (HP:0011869) | 2.69479676 |
| 27 | Impaired platelet aggregation (HP:0003540) | 2.69479676 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 2.65410355 |
| 29 | Increased serum ferritin (HP:0003281) | 2.59926963 |
| 30 | Gonadal dysgenesis (HP:0000133) | 2.57323119 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 2.54828701 |
| 32 | Optic neuritis (HP:0100653) | 2.54828701 |
| 33 | Paralysis (HP:0003470) | 2.51920729 |
| 34 | Cholecystitis (HP:0001082) | 2.51847061 |
| 35 | Abnormal gallbladder physiology (HP:0012438) | 2.51847061 |
| 36 | Loss of speech (HP:0002371) | 2.50242111 |
| 37 | Stomatitis (HP:0010280) | 2.50027870 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 2.48504364 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 2.42202329 |
| 40 | Myositis (HP:0100614) | 2.41273226 |
| 41 | Asymmetric septal hypertrophy (HP:0001670) | 2.40099464 |
| 42 | Increased IgM level (HP:0003496) | 2.40071879 |
| 43 | Hepatosplenomegaly (HP:0001433) | 2.35012824 |
| 44 | Abnormality of iron homeostasis (HP:0011031) | 2.27785350 |
| 45 | Reticulocytosis (HP:0001923) | 2.26609168 |
| 46 | Thin bony cortex (HP:0002753) | 2.25605914 |
| 47 | Recurrent abscess formation (HP:0002722) | 2.25158507 |
| 48 | Mesangial abnormality (HP:0001966) | 2.23828605 |
| 49 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.23128328 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.21260094 |
| 51 | Hypertriglyceridemia (HP:0002155) | 2.19921945 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.18334498 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18184230 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18184230 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18184230 |
| 56 | Myocardial infarction (HP:0001658) | 2.16345077 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.16193651 |
| 58 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.15583122 |
| 59 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11513997 |
| 60 | Hypochromic microcytic anemia (HP:0004840) | 2.09133231 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.09063197 |
| 62 | Hemorrhage of the eye (HP:0011885) | 2.07898986 |
| 63 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.07745758 |
| 64 | Absent/shortened dynein arms (HP:0200106) | 2.07745758 |
| 65 | Axonal loss (HP:0003447) | 2.05196642 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.04134715 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.04134715 |
| 68 | Cholelithiasis (HP:0001081) | 2.03695922 |
| 69 | Acanthocytosis (HP:0001927) | 2.03510311 |
| 70 | Gingivitis (HP:0000230) | 2.02158172 |
| 71 | Basal ganglia calcification (HP:0002135) | 2.01554324 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.01358364 |
| 73 | Abnormality of lateral ventricle (HP:0030047) | 1.99030488 |
| 74 | Joint swelling (HP:0001386) | 1.98547908 |
| 75 | Arterial thrombosis (HP:0004420) | 1.97277362 |
| 76 | Generalized aminoaciduria (HP:0002909) | 1.96509272 |
| 77 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95909137 |
| 78 | Autoimmune thrombocytopenia (HP:0001973) | 1.95362010 |
| 79 | Glomerulopathy (HP:0100820) | 1.94876061 |
| 80 | Glomerulonephritis (HP:0000099) | 1.94749096 |
| 81 | Vertebral compression fractures (HP:0002953) | 1.94076304 |
| 82 | Hyperparathyroidism (HP:0000843) | 1.94008723 |
| 83 | Abnormality of the common coagulation pathway (HP:0010990) | 1.92776174 |
| 84 | Bruising susceptibility (HP:0000978) | 1.91283195 |
| 85 | Erythema (HP:0010783) | 1.90805601 |
| 86 | Nuclear cataract (HP:0100018) | 1.88723260 |
| 87 | Chronic obstructive pulmonary disease (HP:0006510) | 1.87969574 |
| 88 | Obstructive lung disease (HP:0006536) | 1.87969574 |
| 89 | Nephritis (HP:0000123) | 1.87864382 |
| 90 | Distal lower limb muscle weakness (HP:0009053) | 1.86294494 |
| 91 | Rickets (HP:0002748) | 1.85333088 |
| 92 | Gangrene (HP:0100758) | 1.85283993 |
| 93 | Abnormality of the Achilles tendon (HP:0005109) | 1.81825316 |
| 94 | Ileus (HP:0002595) | 1.80273222 |
| 95 | Abnormal ciliary motility (HP:0012262) | 1.80026838 |
| 96 | Microcytic anemia (HP:0001935) | 1.78697759 |
| 97 | Abnormality of complement system (HP:0005339) | 1.77171011 |
| 98 | Abnormality of the costochondral junction (HP:0000919) | 1.76947156 |
| 99 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75714601 |
| 100 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75561210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.24101025 |
| 2 | RIPK4 | 2.97171783 |
| 3 | TAOK2 | 2.90542059 |
| 4 | RIPK1 | 2.84458281 |
| 5 | PRPF4B | 2.65218409 |
| 6 | MAP3K3 | 2.60059545 |
| 7 | ERN1 | 2.40616251 |
| 8 | BMX | 2.22876049 |
| 9 | TRIB3 | 2.15520057 |
| 10 | TBK1 | 2.07387452 |
| 11 | PIM2 | 2.05306537 |
| 12 | TESK1 | 2.00135142 |
| 13 | DDR2 | 1.86477091 |
| 14 | MAP3K11 | 1.82457874 |
| 15 | TAOK1 | 1.80493331 |
| 16 | SIK1 | 1.77906053 |
| 17 | NME2 | 1.67771639 |
| 18 | EPHB1 | 1.66517744 |
| 19 | IKBKB | 1.64156206 |
| 20 | MAP2K3 | 1.63703354 |
| 21 | BLK | 1.58818385 |
| 22 | IKBKE | 1.57035739 |
| 23 | JAK3 | 1.54518010 |
| 24 | ZAP70 | 1.52329006 |
| 25 | MAP3K1 | 1.47628469 |
| 26 | TYK2 | 1.44886365 |
| 27 | MAP3K14 | 1.40168980 |
| 28 | MYLK | 1.37162634 |
| 29 | GRK7 | 1.34731417 |
| 30 | TESK2 | 1.33895534 |
| 31 | MAPKAPK3 | 1.33097889 |
| 32 | BMPR2 | 1.30579154 |
| 33 | IRAK4 | 1.27607706 |
| 34 | MST4 | 1.27335545 |
| 35 | FGR | 1.24651910 |
| 36 | PTK2B | 1.24034939 |
| 37 | PLK4 | 1.23487013 |
| 38 | GRK6 | 1.22856493 |
| 39 | MST1R | 1.20685540 |
| 40 | ICK | 1.19026482 |
| 41 | EIF2AK1 | 1.18403936 |
| 42 | BTK | 1.16771168 |
| 43 | MATK | 1.14927009 |
| 44 | ARAF | 1.14845600 |
| 45 | SIK3 | 1.13321297 |
| 46 | EPHA2 | 1.12885291 |
| 47 | CDK12 | 0.99106012 |
| 48 | PDPK1 | 0.98773091 |
| 49 | MAP4K1 | 0.98304010 |
| 50 | CSK | 0.94699948 |
| 51 | PIK3CG | 0.93962893 |
| 52 | FGFR4 | 0.93760276 |
| 53 | BRD4 | 0.91560026 |
| 54 | MOS | 0.88343487 |
| 55 | JAK1 | 0.87293416 |
| 56 | TNK2 | 0.86960002 |
| 57 | CDC42BPA | 0.85572366 |
| 58 | KSR2 | 0.84791410 |
| 59 | MARK3 | 0.84125697 |
| 60 | PAK1 | 0.82953707 |
| 61 | SYK | 0.82845104 |
| 62 | CHUK | 0.81370780 |
| 63 | CSF1R | 0.80875743 |
| 64 | ILK | 0.80502486 |
| 65 | JAK2 | 0.80195822 |
| 66 | MAP3K5 | 0.80166373 |
| 67 | STK38 | 0.77956260 |
| 68 | HIPK2 | 0.75480071 |
| 69 | PDK1 | 0.75300519 |
| 70 | PKN2 | 0.74523392 |
| 71 | DYRK1B | 0.72682066 |
| 72 | IRAK1 | 0.70834127 |
| 73 | HCK | 0.69085886 |
| 74 | GRK5 | 0.68163776 |
| 75 | MAPK15 | 0.63873320 |
| 76 | ABL2 | 0.63144028 |
| 77 | LYN | 0.60973798 |
| 78 | RPS6KA2 | 0.56761900 |
| 79 | EPHB2 | 0.55147602 |
| 80 | DAPK3 | 0.54725420 |
| 81 | PAK4 | 0.54475591 |
| 82 | TGFBR2 | 0.52585937 |
| 83 | IRAK2 | 0.50223007 |
| 84 | MARK2 | 0.48763944 |
| 85 | EPHA3 | 0.48639372 |
| 86 | MAPK11 | 0.48454216 |
| 87 | MAP3K8 | 0.47987892 |
| 88 | MAP3K2 | 0.47510552 |
| 89 | BRAF | 0.47209185 |
| 90 | CLK1 | 0.43574949 |
| 91 | SIK2 | 0.43482428 |
| 92 | PIM1 | 0.43231649 |
| 93 | STK10 | 0.42967433 |
| 94 | SMG1 | 0.41933185 |
| 95 | MAP3K6 | 0.41239270 |
| 96 | MAPKAPK2 | 0.40602512 |
| 97 | PRKG2 | 0.38640445 |
| 98 | LATS2 | 0.37588885 |
| 99 | DYRK3 | 0.37167740 |
| 100 | PKN1 | 0.36711395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.62609176 |
| 2 | Malaria_Homo sapiens_hsa05144 | 2.52549887 |
| 3 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.29041079 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.21297232 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.16878729 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.07646536 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01025623 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87193626 |
| 9 | Influenza A_Homo sapiens_hsa05164 | 1.84066681 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81996824 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 1.70397128 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.67026229 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.64364065 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.64242231 |
| 15 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.57414304 |
| 16 | Hepatitis C_Homo sapiens_hsa05160 | 1.54622467 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.48150743 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.48128698 |
| 19 | Platelet activation_Homo sapiens_hsa04611 | 1.47790602 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.47590189 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47043243 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.46682064 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.44929880 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37767480 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35772158 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27825962 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27684092 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.26992702 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.26067384 |
| 30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23806901 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.22805587 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22077248 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21156323 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19079621 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.17337308 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16528478 |
| 37 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16068533 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.15811544 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14994221 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11424881 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.09794696 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09624773 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.09085358 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.08552423 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.06907132 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.05752437 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05651234 |
| 48 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.01771734 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 1.01262020 |
| 50 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98953925 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98809615 |
| 52 | Endocytosis_Homo sapiens_hsa04144 | 0.98529791 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.93692452 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93628670 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92307546 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90017446 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88745064 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.88205029 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86965806 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.86031743 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83086825 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82406676 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78605681 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75493628 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75210925 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.74718506 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74217155 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.73906832 |
| 69 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73138260 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72765995 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72530344 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70611897 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.69976064 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69366619 |
| 75 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67389774 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66722383 |
| 77 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66450131 |
| 78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66112142 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65846292 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63849816 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63724017 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61476873 |
| 83 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61174394 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60699439 |
| 85 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60301217 |
| 86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59063015 |
| 87 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57108716 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52240864 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51897251 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51677480 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51094679 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49215455 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48351439 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.45467511 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.43956998 |
| 96 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.43888063 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43277550 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42357276 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41429245 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41315520 |

